Gary S. Sachs

Q: What Schools Are Affiliated With Gary S. Sachs

Gary S. Sachs is affiliated with the following schools: Indiana University, Massachusetts General Hospital

Gary S. Sachs's AcademicInfluence.com Rankings

Gary S. Sachs

Biology

#11560

World Rank

#14963

Historical Rank

biology Degrees

Download Badge

Biology

Gary S. Sachs's Degrees

Doctorate Medicine Harvard University

Why Is Gary S. Sachs Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gary S. Sachs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. (2000) (1309)
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder (2008) (1189)
A double- Blind placebo-controlled study of lamotriqine monotherapy outpatients with bipolar I depression (1999) (842)
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. (2003) (819)
Effectiveness of adjunctive antidepressant treatment for bipolar depression. (2007) (817)
Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) (2004) (814)
Whole-genome association study of bipolar disorder (2008) (714)
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. (2003) (626)
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. (2003) (590)
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2004) (555)
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2006) (531)
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) (2003) (499)
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. (2007) (464)
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder (2000) (446)
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. (2000) (431)
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. (2002) (418)
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. (2002) (391)
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. (2009) (388)
Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? (1999) (374)
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. (2001) (355)
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. (2005) (335)
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. (2005) (332)
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. (1999) (313)
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. (2006) (294)
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. (2009) (293)
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone (2004) (288)
A double-blind trial of bupropion versus desipramine for bipolar depression. (1994) (276)
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. (2004) (266)
Clinical and Diagnostic Implications of Lifetime Attention-Deficit/Hyperactivity Disorder Comorbidity in Adults with Bipolar Disorder: Data from the First 1000 STEP-BD Participants (2005) (255)
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. (2014) (250)
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. (2009) (242)
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study (2006) (238)
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. (2006) (227)
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders (2006) (202)
Psychopathology in the Offspring of Parents with Bipolar Disorder: A Controlled Study (2005) (198)
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. (2010) (197)
Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. (2000) (194)
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. (2007) (193)
RESEARCH: Cognitive Rehabilitation for Bipolar Disorder: An Open Trial for Employed Patients with Residual Depressive Symptoms (2010) (191)
Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) (2006) (189)
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. (2007) (189)
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. (2002) (177)
Weight gain associated with use of psychotropic medications. (1999) (169)
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. (2002) (169)
Bipolar depression: pharmacotherapy and related therapeutic strategies (2000) (158)
An open-label trial of divalproex in children and adolescents with bipolar disorder. (2002) (153)
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. (2008) (152)
The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. (1997) (147)
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. (2009) (145)
A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. (2009) (142)
A clinical monitoring form for mood disorders. (2002) (139)
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. (2009) (136)
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. (2009) (136)
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. (2000) (135)
Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies. (2004) (134)
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. (2004) (133)
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. (2006) (132)
Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. (2005) (131)
Does recovery from substance use disorder matter in patients with bipolar disorder? (2005) (131)
Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart Review (2000) (129)
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. (2002) (129)
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2007) (126)
Valproate Is Associated with New-Onset Oligoamenorrhea with Hyperandrogenism in Women with Bipolar Disorder (2006) (122)
Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2009) (121)
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. (2006) (120)
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. (2006) (120)
Pharmacological management of agitation in emergency settings (2003) (117)
Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2004) (117)
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. (2003) (114)
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. (2002) (112)
Bipolar Mood Disorder: Practical Strategies for Acute and Maintenance Phase Treatment (1996) (107)
Treatment-resistant bipolar depression. (1996) (106)
Sleep disturbance in euthymic bipolar patients (2012) (105)
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. (2010) (105)
Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. (2010) (105)
Strategies for improving treatment of bipolar disorder: integration of measurement and management (2004) (105)
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2010) (103)
Sleep matters: sleep functioning and course of illness in bipolar disorder. (2011) (103)
Pharmacotherapy for Bipolar Disorder and Comorbid Conditions: Baseline Data From STEP-BD (2004) (100)
Hypochondriacal concerns, anxiety sensitivity, and panic disorder (1992) (99)
Bipolar disorder therapeutics: maintenance treatment (2000) (98)
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. (2000) (98)
Perceived criticism from family members as a predictor of the one-year course of bipolar disorder (2005) (97)
Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial. (2015) (96)
Personality and bipolar disorder: dissecting state and trait associations between mood and personality (2010) (95)
Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. (2019) (95)
The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. (2004) (93)
Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder. (2003) (91)
A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. (1988) (89)
Side effects induced by bright light treatment for seasonal affective disorder. (1994) (86)
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. (2003) (86)
Long‐term risperidone treatment in bipolar disorder: 6‐month follow up* (1997) (85)
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. (2006) (84)
Characteristics of non-verbal memory impairment in bipolar disorder: the role of encoding strategies (2004) (84)
Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. (2006) (82)
Childhood antecedent disorders to bipolar disorder in adults: a controlled study. (2007) (81)
Transition to Mania During Treatment of Bipolar Depression (2010) (80)
Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2006) (79)
Influence of sub-syndromal symptoms after remission from manic or mixed episodes (2006) (79)
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. (2011) (78)
Manual-based group psychotherapy for bipolar disorder: a feasibility study. (1998) (77)
Revisiting Depressive-Prone Bipolar Disorder: Polarity of Initial Mood Episode and Disease Course Among Bipolar I Systematic Treatment Enhancement Program for Bipolar Disorder Participants (2005) (76)
Donepezil in treatment-resistant bipolar disorder (1999) (75)
Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups (2003) (74)
Clinical practice guidelines: praise and problems. (1999) (74)
Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium-treated patients (1996) (74)
Caregiver Burden and Health in Bipolar Disorder: A Cluster Analytic Approach (2008) (73)
Acute Treatment of Bipolar Disorder with Adjunctive Risperidone in Outpatients (1997) (72)
31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis (2001) (71)
A review of agitation in mental illness: burden of illness and underlying pathology. (2006) (69)
Impaired Recruitment of the Dorsolateral Prefrontal Cortex and Hippocampus During Encoding in Bipolar Disorder (2006) (69)
Inositol augmentation of lithium or valproate for bipolar depression. (2006) (68)
Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. (2008) (68)
Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. (2002) (67)
Overweight and obesity in bipolar disorders. (2006) (65)
Brain GABA levels in patients with bipolar disorder (2009) (65)
Unmet Clinical Needs in Bipolar Disorder (2003) (64)
Cigarette smoking is associated with suicidality in bipolar disorder. (2009) (62)
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. (2006) (62)
Use of clonazepam for bipolar affective disorder. (1990) (61)
Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD) (2012) (59)
Two 6-Week, Randomized, Double-Blind, Placebo-Controlled Studies of Ziprasidone in Outpatients With Bipolar I Depression: Did Baseline Characteristics Impact Trial Outcome? (2012) (56)
Association Between Therapeutic Alliance, Care Satisfaction, and Pharmacological Adherence in Bipolar Disorder (2013) (55)
Variability of brain lithium levels during maintenance treatment: A magnetic resonance spectroscopy study (1995) (54)
Five-factor personality traits in patients with seasonal depression: treatment effects and comparisons with bipolar patients. (1999) (54)
Citalopram as adjunctive therapy in bipolar depression. (2001) (52)
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder (2009) (51)
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials (2010) (51)
Predictors of bipolar disorder risk among patients currently treated for major depression. (2006) (50)
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. (2011) (49)
Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals? (2003) (49)
Longitudinal Follow-up of Reproductive and Metabolic Features of Valproate-Associated Polycystic Ovarian Syndrome Features: A Preliminary Report (2006) (49)
Weight gain during treatment of bipolar I patients with olanzapine. (2004) (49)
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. (2006) (49)
Assuring that double-blind is blind. (2010) (48)
Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder. (2005) (48)
A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. (2006) (46)
Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter (2005) (46)
Akathisia: a review and case report following paroxetine treatment. (1996) (46)
The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: An in vivo proton magnetic resonance spectroscopy study (1992) (46)
Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. (2006) (46)
Galantamine‐ER For Cognitive Dysfunction In Bipolar Disorder and Correlation with Hippocampal Neuronal Viability: A Proof‐of‐Concept Study (2009) (46)
An fMRI investigation of working memory and sadness in females with bipolar disorder: a brief report. (2008) (46)
Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. (2019) (45)
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. (2009) (44)
Major depression and the basal ganglia. (1997) (43)
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. (2006) (42)
Medication Treatment of Bipolar Disorder 2000: A Summary of the Expert Consensus Guidelines (2000) (42)
Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts. (2005) (41)
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. (1993) (41)
Age onset of psychotic versus non-psychotic bipolar illness in men and in women. (2003) (40)
Measurement of human brain lithium in vivo by MR spectroscopy. (1993) (40)
Maintenance therapies for classic and other forms of bipolar disorder. (2000) (40)
ECNP consensus meeting March 2000: Nice guidelines for investigating efficacy in bipolar disorder (2001) (39)
Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. (2007) (39)
Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. (2007) (38)
Lithium Monotherapy: Miracle, Myth and Misunderstanding (1994) (38)
Presence of Irritability During Depressive Episodes in Bipolar Disorder (2004) (38)
The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. (2006) (36)
What is to be done? Controversies in the Diagnosis and Treatment of Manic-Depressive Illness (2000) (36)
Polypharmacy and bipolar disorder: what's personality got to do with it? (2014) (36)
Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP‐BD study (2017) (35)
The expert consensus guideline series (2009) (32)
Bipolar depression: relationship between episode length and antidepressant treatment (2002) (32)
Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions (2002) (31)
Omega-3 fatty acids in bipolar disorder: clinical and research considerations. (2006) (31)
Adjunctive treatment of acute mania: a clinical overview (2007) (31)
Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. (1990) (31)
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. (2021) (30)
Integration of suicide prevention into outpatient management of bipolar disorder. (2001) (30)
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. (2007) (30)
Insight in seasonal affective disorder. (1997) (29)
The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study. (2018) (28)
Decision tree for the treatment of bipolar disorder. (2003) (28)
The Bipolarity Index: a clinician-rated measure of diagnostic confidence. (2015) (28)
Proton mrs of the basal ganglia in bipolar disorder Massachusetts General Hospital and McLean Hospital, Harvard Consolidated Department of Psychiatry, Boston, MA (1994) (27)
Psychosocial Service Utilization by Patients with Bipolar Disorders: Data from the First 500 Participants in the Systematic Treatment Enhancement Program (2004) (27)
Phototherapy for seasonal affective disorder: a blind comparison of three different schedules. (1994) (26)
Suicidal ideation and pharmacotherapy among STEP-BD patients. (2005) (26)
Psychosocial strategies to improve concordance and adherence in bipolar disorder. (2006) (25)
Treatment emergent affective switch: a controlled study. (2004) (24)
Childhood History of Anxiety in Adults with Panic Disorder: Association with Anxiety Sensitivity and Comorbidity (1994) (24)
Cognitive Behavioral Therapy for Rapid-Cycling Bipolar Disorder: A Pilot Study (2007) (24)
Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. (2005) (23)
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. (2010) (23)
Suicide prevention: increasing education and awareness. (2001) (23)
Dysfunctional Attitudes, Attributional Styles, and Phase of Illness in Bipolar Disorder (2010) (23)
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. (2012) (22)
Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled 31P magnetic resonance spectroscopy study (2001) (21)
Do antidepressants induce rapid cycling? A gender-specific association. (2003) (21)
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles (2012) (21)
Changes in Regional Cerebral Blood Flow following Light Treatment for Seasonal Affective Disorder: Responders versus Nonresponders (1997) (21)
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. (2004) (20)
Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial. (2017) (20)
Administration of antidepressants. Single versus split dosing: a meta-analysis. (2001) (20)
The pharmacologic treatment of bipolar disorder. (2011) (18)
Characteristics of rapid cycling bipolar-I patients in a bipolar speciality clinic. (2004) (18)
Influence of phototherapy treatment duration for seasonal affective disorder: Outcome at one vs. two weeks (1995) (18)
Treatment of bipolar depression (1998) (18)
Rates of study completion with single versus split daily dosing of antidepressants: a meta-analysis. (2004) (17)
Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. (2006) (17)
Correlates of functioning in bipolar disorder. (2008) (16)
Psychosocial Interventions as Adjunctive Therapy for Bipolar Disorder (2008) (16)
Enhancement of ECT benefit by yohimbine. (1986) (15)
Stability of symptoms across major depressive episodes in bipolar disorder. (2009) (15)
Increased rate of non-right-handedness in patients with bipolar disorder. (2008) (15)
Linkage disequilibrium mapping of the chromosome 6q21–22.31 bipolar I disorder susceptibility locus (2009) (15)
Regional cerebral blood flow changes after light therapy in seasonal affective disorder (1996) (14)
Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach. (2003) (14)
Observational data on the antiagitation effect of risperidone tablets in emergency settings: A preliminary report (2003) (13)
Quetiapine vs placebo as adjunct to mood stabilizer for the treatment of acute mania (2002) (13)
Ergoloid mesylates and ECT. (1989) (12)
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania (2021) (12)
Increasing minority research participation through collaboration with community outpatient clinics: the STEP-BD Community Partners Experience (2009) (11)
Is Divalproex Sodium an Appropriate Initial Treatment for Bipolar Depression (1996) (11)
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection. (2012) (11)
Treatment of Bipolar Disorder: A Guide for Patients and Families (2000) (11)
Bipolar-I depression outpatient treatment quality and costs in usual care practice. (2008) (11)
Olanzapine in the treatment of bipolar depression (2002) (11)
Adjuncts and alternatives to lithium therapy for bipolar affective disorder. (1989) (10)
Lithium-induced alterations in nucleoside triphosphate levels in human brain: a proton-decoupled 31P magnetic resonance spectroscopy study (2005) (10)
Bipolar diagnosis in China: Evaluating diagnostic confidence using the Bipolarity Index. (2016) (10)
Implementing evidence-based treatment of manic and mixed episodes. (2006) (9)
Paroxetine for bipolar depression: Outcome in patients failing prior antidepressant trials (1995) (9)
Improving outcomes in patients with bipolar depression: a comprehensive review. (2015) (9)
Topiramate in the treatment of refractory bipolar mood disorder (1999) (8)
A 25-year-old woman with bipolar disorder. (2001) (8)
Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. (2009) (8)
Fast Facts: Bipolar Disorder (2010) (8)
Diagnosing Mania in the Age of DSM-5. (2017) (8)
Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression. (2018) (7)
Frequency of use and perceived helpfulness of wellness strategies for bipolar and unipolar depression. (2018) (7)
Implementing machine learning in bipolar diagnosis in China (2019) (7)
Bipolar Disorder Clinical Synthesis: Where Does the Evidence Lead? (2007) (7)
Lamotrigine delays mood episodes in recently depressed bipolar I patients (2002) (7)
Update on bipolar disorder and substance abuse: recent findings and treatment strategies. (2006) (7)
The interactive computer interview for mania. (2010) (7)
Psychopathology in Children of Late versus Early Onset Bipolar Probands (1994) (7)
Efficacy and tolerability of risperidone versus placebo in combination with lithium or valproate in acute mania (2000) (6)
Unmet needs in the assessment and management of bipolar I depression. (2013) (6)
Sleep matters: Sleep functioning and course of illness in bipolar disorder (2011) (6)
Lamotrigine in rapid cycling bipolar disorder: Predictors of response in a double-blind, placebo-controlled maintenance study (2001) (6)
Focus on bipolar disorder treatment. (2005) (6)
Do antidepressants induce rapid cycling? A gender specific association (2001) (6)
Applying Association Rules to Study Bipolar Disorder and Premenstrual Dysphoric Disorder Comorbidity (2018) (6)
Brief report: paroxetine in younger and adult individuals at high risk for suicide. (2006) (5)
Improving Well-Being (2008) (5)
Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments. (2015) (5)
Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients (2006) (5)
Managing Bipolar Disorder: Therapist Guide: A cognitive-behavioural approach (2008) (4)
Phototherapy-induced hot flushes. (1994) (4)
Forecasting depressive relapse in Bipolar Disorder from clinical data (2018) (4)
Recent advances in the treatment of bipolar depression (2007) (4)
The authors reply [4] (2007) (4)
Psychosocial Interventions: Empirically-Derived Treatments for Bipolar Disorder (2008) (4)
A US perspective of the CANMAT bipolar guidelines. (2005) (3)
Pharmacological treatment of acute bipolar depression (2009) (3)
Managing Bipolar Disorder: Workbook: A cognitive-behavioural approach (2008) (3)
The challenges of pharmacotherapy of bipolar depression (2002) (3)
Effect of lithium on posphoinositide metabolism in human brain: A proton decoupled 31P magnetic resonance spectroscopy study (2001) (2)
P.1.210 Concomitant use of lamotrigine and valproate in bipolar I disorder (2003) (2)
Bipolar disorder: current treatments and new strategies. (1998) (2)
Moving the Field Forward 09 : 0010 : 30 THE INTERNATIONAL SOCIETY OF BIPOLAR DISORDERS TASK FORCE ON THE NOMENCLATURE OF COURSE AND OUTCOME IN BIPOLAR DISORDERS (2007) (2)
Bipolar Disorders: Investigational strategies: treatment of rapid cycling, mixed episodes, and atypical bipolar mood disorder (2005) (2)
Moving the Field Forward 09 : 0010 : 30 THE INTERNATIONAL SOCIETY OF BIPOLAR DISORDERS TASK FORCE ON THE NOMENCLATURE OF COURSE AND OUTCOME IN BIPOLAR DISORDERS (2007) (2)
Academic Highlights: The Evolving Paradigm for Bipolar Disorder. [CME] (2007) (1)
P.2.d.024 Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder (2013) (1)
Dr. Goldberg replies (American Journal of Psychiatry (February 2008) 165 (264)) (2008) (1)
Session 1: Introduction (2008) (1)
Treatment of bipolar depression with citalopram (2001) (1)
P.2.b.049 Increasing signal over noise in MDD clinical trials: improvement after efficacy scale rater training among experienced MDD investigators (2013) (1)
P.1.213 Safety and tolerability of lamotrigine in bipolar I disorder (2003) (1)
Academic Highlights: Emerging Therapies for Bipolar Depression. [CME] (2006) (1)
Bipolar disorder and premenstrual disphoric disorder comorbidity: Apriori algorithm study (2018) (1)
Adding a nurse-based intervention programme to usual care improves manic symptoms in people with bipolar disorder (2005) (1)
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. (2023) (1)
Comprar Living with Bipolar Disorder A Guide for Individuals and Families | Michael W. Otto | 9780199782024 | Oxford University Press (2011) (0)
Tolerability of single versus split daily dosing of antidepressants: A meta-analysis (2002) (0)
A study of informed consent (IC), age, and cognitive performance (CP) among advanced cancer patients (acp) in phase I trials (2007) (0)
Clinical correlates of premenstrual worsening of mood in women with bipolar disorder (2008) (0)
P.2.e.030 Why do clinical trials fail? Learning from computer administered assessments (2011) (0)
P.1.043 Lithium induced alterations in NTP levels in human brain: A proton decoupled 31P MRS study (2003) (0)
Managing Extreme Emotions Module (2008) (0)
Demographic and diagnostic features of the studies comparing benzodiazepines , classic antipsychotics , and the combination of both in the treatment of acute agitation (2003) (0)
Risperidone treatment for acute mania: assessment of tolerability (2000) (0)
C.06.01 Treating manic symptoms: from theory to practice (2008) (0)
P.2.d.045 What blinded raters don’t see: relapse events in a bipolar study detected by site-based raters versus a computer simulated rater (2016) (0)
Treatment of mixed episodes (2001) (0)
Bipolar Disorder: Information, Advocacy, and Research (2000) (0)
CLONAZPAM AND BIPOLAR AFFECTIVE DISORDER. AUTHOR'S REPLY (1990) (0)
Introduction to the Problem-List Phase (2008) (0)
Lamotrigine and lithium as maintenance treatment for bipolar I disorder (2004) (0)
Erratum: Measurement of human brain lithium in vivo by MR spectroscopy (American Journal of Neuroradiology (September/October 1993)) (1993) (0)
Session 13: Hypomanic Cognitive Errors (2008) (0)
Sessions 5 and 6: Cognitive Restructuring—Part III (2008) (0)
The evolving paradigm for bipolar disorder. (2007) (0)
post hoc analysis of pooled data from short-and long-term aripiprazole trials Evaluation of akathisia in patients with schizophrenia , schizoaffective disorder , or bipolar I disorder : a (2010) (0)
Abstracts from the 3rd Biennial Conference of the International Society for Bipolar Disorders. January 27-28, 2008. Delhi, India. January 30, 2008. Agra, India. (2008) (0)
Abstracts from the 3rd Biennial Conference of the International Society for Bipolar Disorders. January 27-28, 2008. Delhi, India. January 30, 2008. Agra, India. (2008) (0)
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: Results of a Randomized Phase 3 Placebo-Controlled Study (Study 301) (2023) (0)
Session 5: Cognitive Restructuring—Part III (2008) (0)
Suicidal Ideation and Pharmacotherapy STEP-BD (2006) (0)
Problem-Solving Module (2008) (0)
Anger Management Module (2008) (0)
manic or mixed episodes Influence of sub-syndromal symptoms after remission from (2011) (0)
Sessions 10–12: Drafting a Treatment Contract (2008) (0)
istration of the MADRS in Placebo Controlled Trials (2011) (0)
Bipolarity Index--Chinese Version (2016) (0)
Cognitive performance (cp), informed consent (ic), and age among advanced cancer patients (acp) (2008) (0)
Session 9: More Work With Core Beliefs (2008) (0)
Well-Being Therapy and Relapse Prevention (2008) (0)
In reply [3] (2007) (0)
Brain lithium levels measured by MRS: Variability during maintenance treatment in bipolar disorder (1994) (0)
P.3.f.026 Could a simplified PANSS be more efficient? (2013) (0)
Bibliography B IPOLAR D ISORDER (2011) (0)
Session 6: Cognitive Restructuring—Part III (2008) (0)
Session 7: Core Beliefs (2008) (0)
Charles Bowden, MD, 1938-2022. (2022) (0)
Treatments for Depression in Bipolar II Disorder. (2022) (0)
Introductory Information for Therapists (2009) (0)
Session 3: Cognitive Restructuring—Part I (2008) (0)
Management of Comorbid Anxiety Disorders Module (2008) (0)
Cognitive function (CF) and prognostic information understanding in advanced cancer patients (ACP). (2009) (0)
Circadian gene polymorphisms and liability to bipolar I disorder (2007) (0)
P.2.e.018 Analysis of the impact of family history subgroups on drug-placebo separation and placebo response in RCTs (2012) (0)
Use of computer interviews to increase diagnostic confidence for bipolar disorders (2011) (0)
Safety monitoring of bipolar disorder treatment: ISBD consensus guidelines (2008) (0)
Preventing relapse in bipolar disorder (2006) (0)
Dr.Goldberg replies (vol 165, pg 264, 2008) (2008) (0)
Session 8: Challenging Core Beliefs (2008) (0)
Overview of Treatment Structure and Strategies (2008) (0)
P.3.f.024 Within person variance as a quality metric – an exploratory analysis identifying outlier sites in schizophrenia clinical trials (2017) (0)
Increasing Signal Over Noise in MDD Clinical Trials: Rating Improvement After Efficacy Scale Training Among Experienced MDD Investigators (2015) (0)
Social Skills Training Module (2008) (0)
Session 2: Mood Charting and Activity Scheduling (2008) (0)
Linking Panic Disorder and Depression: the Fatigue Dimension (1991) (0)
The End of Treatment (2008) (0)
O-102 Systematic advance care planning in the nursing home: preliminary outcomes from the optimistic (optimising patient transfers, impacting medical quality, and improving symptoms: transforming institutional care) demonstration project (2015) (0)
maintenancetreatmentofbipolarIdisorder:Long-term changes in weight and metabolic profiles (2012) (0)
Session 4: Cognitive Restructuring—Part II (2008) (0)
C.08.03 Major depressive disorder (MOD) and bipolar depression: different diagnoses, same treatment? (2006) (0)
Update on best practices for managing bipolar depression. (2014) (0)
Use of risperidone in psychotic and non-psychotic patients with bipolar disorder (2000) (0)
Affective switch: Towards a consensus definition (2008) (0)
Is Psychosocial Management Effective? Authors' reply (2007) (0)
Breathing and Relaxation (2008) (0)
Breathing and Relaxation Strategies Module (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gary S. Sachs?

Gary S. Sachs is affiliated with the following schools: